Deca 200 / NPP 150
Deca 200 / NPP 150 Dragon Pharma — Overview
Deca 200 / NPP 150 Dragon Pharma is a dual-ester nandrolone blend combining Nandrolone Decanoate at 200 mg/ml and Nandrolone Phenylpropionate at 150 mg/ml in a single 350 mg/ml solution. Both esters deliver the same active hormone — nandrolone — but with different release kinetics: the decanoate ester provides a sustained 14–15 day release that maintains stable baseline levels between injections, while the phenylpropionate ester peaks faster (within 24–48 hours) and clears in approximately 4–5 days, front-loading the anabolic effect at the start of the cycle and after each injection. The combination produces a more immediate onset than pure Deca-300 while retaining the stable long-acting base that single-injection-per-week protocols require.
Nandrolone has one of the most favorable anabolic-to-androgenic ratios among injectable steroids — approximately 125:37 relative to testosterone — and is well-established both in clinical medicine (muscle wasting, anemia, osteoporosis) and performance use. It does not convert to DHT in androgen-sensitive tissues, which significantly reduces scalp, skin, and prostate androgenic burden compared to testosterone. However, nandrolone raises prolactin and has progestogenic activity, which requires dedicated management and differentiates its side effect profile from testosterone-based compounds. Exogenous testosterone must always be included alongside nandrolone to maintain androgen levels and prevent the sexual dysfunction associated with running nandrolone without a testosterone base.
About the Compound: Nandrolone Decanoate + Phenylpropionate
Nandrolone is a 19-nor testosterone derivative — chemically identical to testosterone except for the removal of the carbon-19 methyl group. This structural change alters the hormone's interaction with 5-alpha reductase: rather than converting to the potent DHT (as testosterone does), nandrolone converts to dihydronandrolone, which is a significantly weaker androgen at receptor sites in skin, scalp, and prostate. The result is a compound that is highly anabolic in muscle tissue but produces substantially less androgenic activity in sensitive tissues than testosterone at equivalent doses.
Nandrolone exerts its anabolic effects through androgen receptor activation in skeletal muscle, nitrogen retention, IGF-1 upregulation, and satellite cell stimulation. It also has a pronounced effect on collagen synthesis — nandrolone upregulates type I and type III collagen production and increases proteoglycan content in connective tissue, producing the joint-cushioning and tendon-supportive effect that nandrolone is well-known for in both clinical and performance contexts. Users with chronic joint pain from high-volume training frequently report significant pain reduction within 4–6 weeks of nandrolone use.
The dual-ester design in Deca 200 / NPP 150 addresses the main limitation of pure nandrolone decanoate — the slow, 3–4 week buildup to peak plasma levels. The NPP component reaches effective tissue concentrations within the first week, producing measurable anabolic effect while the decanoate fraction is still accumulating. After the first 2–3 weeks, both esters contribute to a sustained steady-state nandrolone level that is maintained with once- or twice-weekly injections for the remainder of the cycle.
Nandrolone aromatizes to estradiol at roughly 20% of testosterone's rate, producing modest estrogen elevation at standard doses. More clinically significant is nandrolone's progestogenic activity: it binds progesterone receptors and elevates prolactin through this mechanism. Elevated prolactin can cause gynecomastia (which is resistant to standard AIs and requires cabergoline, not anastrozole, for management), sexual dysfunction, and mood changes. This distinction — prolactin-mediated rather than estrogen-mediated side effects — is the defining pharmacological feature of nandrolone compared to purely estrogenic compounds.
What Deca 200 / NPP 150 Does
- Lean mass accrual with lower water retention than testosterone — nandrolone's low aromatization rate produces less estrogen-driven water retention than equivalent testosterone doses; the mass gained on a nandrolone cycle is therefore proportionally leaner than on a pure testosterone cycle, though some water retention occurs via progesterone-mediated mechanisms and the water-retaining effects of the testosterone base in the stack; at 400 mg/week the rate of lean mass gain is comparable to testosterone enanthate at similar doses in controlled studies, with the texture of the gains typically described as fuller and dryer
- Joint support and connective tissue health — nandrolone is the most effective anabolic steroid for joint pain management, operating through upregulation of collagen synthesis (type I and III), increased proteoglycan production in cartilage, and enhanced synovial fluid secretion; users with chronic shoulder, knee, elbow, or hip pain from heavy training report that 200–300 mg/week of nandrolone reduces pain scores within 4–6 weeks; this makes Deca 200 / NPP 150 particularly relevant for intermediate-to-advanced lifters with accumulated joint wear
- Nitrogen retention and protein synthesis — nandrolone produces a strongly positive nitrogen balance at performance doses, indicating net muscle protein synthesis exceeding breakdown; the nitrogen retention effect is disproportionately large relative to its androgenic activity, reflecting the compound's high anabolic selectivity; this translates to sustained lean mass accumulation throughout the cycle without the plateau that some users observe with testosterone-only protocols
- Red blood cell production and recovery — like testosterone, nandrolone stimulates EPO production and erythropoiesis, improving oxygen-carrying capacity and recovery from training; the effect is well-documented in the clinical literature (nandrolone decanoate was historically used to treat anemia); the practical outcome is improved training capacity and faster recovery between sessions, supporting higher training volumes during the cycle
- Dual-phase onset from the ester blend — the NPP component produces measurable anabolic effect in weeks 1–2 that pure Deca-300 cannot provide due to the slow decanoate buildup; users experience earlier onset of nitrogen retention, improved training recovery, and joint lubrication compared to single-ester decanoate protocols, while still benefiting from the stable sustained release that avoids the frequent injections NPP-only cycles require
Who It's For
- Bulking cycle addition to a testosterone base — Deca 200 / NPP 150 is used as the second compound in mass-building cycles alongside Cypionat 250 or another testosterone; nandrolone contributes synergistic anabolic effects through partially overlapping and partially distinct receptor-level mechanisms from testosterone; the testosterone + nandrolone combination at 400–500 mg/week each is the most historically proven mass-building injectable stack and remains the standard reference for bulking cycles
- Athletes with chronic joint pain — users carrying shoulder, knee, elbow, or hip joint issues from years of heavy lifting benefit directly from nandrolone's connective tissue effects; the joint-supportive effect is clinically meaningful at 200 mg/week and allows sustained high-intensity training that would otherwise be limited by pain; this use case does not require the higher anabolic doses used for pure mass — 200–300 mg/week achieves most of the joint benefit
- Intermediate-to-advanced users seeking leaner mass than testosterone alone — the lower aromatization rate and DHT conversion of nandrolone produce a leaner mass-to-water ratio than high-dose testosterone; users who find that testosterone-only cycles produce excessive water retention and puffiness often switch to test + nandrolone stacks where a moderate testosterone dose is paired with higher nandrolone, shifting the anabolic-to-estrogenic balance in favor of leaner gains
- Users who prefer dual-ester kinetics over single-ester nandrolone — Deca-300 (decanoate only) requires 3–4 weeks to reach effective plasma levels and produces a very slow taper on cycle end; NPP-only requires injections every 2–3 days; Deca 200 / NPP 150 bridges both — faster onset than Deca-300 with less injection frequency than NPP, providing a practical protocol for users who want nandrolone's benefits without committing to either extreme of injection scheduling
Combinations
Deca 200 / NPP 150 always requires an exogenous testosterone base. The following Dragon Pharma combinations address specific cycle goals:
| Goal | Addition | Rationale |
|---|---|---|
| Testosterone base (mandatory) | Cypionat 250 Dragon Pharma | Nandrolone is highly suppressive and does not provide sufficient androgenic activity to maintain libido, mood, and sexual function when run alone; exogenous testosterone at a minimum of 200 mg/week — and typically 300–400 mg/week in a bulking context — is required to maintain baseline androgen levels and prevent the sexual dysfunction and mood deterioration associated with low DHT in the presence of nandrolone; Cypionat 250's long ester matches the Deca component's injection frequency, making the two compounds a natural pairing |
| Oral kickstart for rapid early mass | Dianabol 50 Dragon Pharma | Even with the NPP component providing faster onset than Deca-300, weeks 1–3 are a ramp-up period; dianabol at 30–50 mg/day in weeks 1–4 provides immediate mass and strength while both nandrolone esters accumulate; once the blend reaches full plasma concentration the oral kickstart is discontinued; estrogenic management requires attention as both dianabol and the testosterone base aromatize |
| Quality lean mass without kickstart | Anavar 50 Dragon Pharma | Anavar (oxandrolone) is a dry, low-androgenic oral that adds lean mass without aromatization or significant estrogenic contribution; combined with the test + nandrolone base it adds strength and vascularity without the water retention of dianabol; suitable for users who prioritize lean, keepable gains over maximum mass accumulation; typically run at 50 mg/day for weeks 6–12 once the injectable base has fully loaded |
| Higher-dose nandrolone decanoate top-up | Deca-300 Dragon Pharma | Users who want to increase total weekly nandrolone dose beyond what Deca 200 / NPP 150 provides can add Deca-300 alongside it; this raises total nandrolone volume while maintaining the dual-ester kinetics from the blend; this approach is used by advanced users running 600+ mg/week nandrolone who need more decanoate volume for stable long-acting levels while the NPP component still handles onset and between-injection peaks |
| Pure short-ester nandrolone protocol | NPP 150 Dragon Pharma | For users who want nandrolone with faster clearance — shorter PCT wait, tighter cycle timing, or competition considerations — NPP 150 alone replaces the blend; the trade-off is E3D injection frequency; alternatively, adding NPP 150 to the Deca 200 / NPP 150 blend shifts the total ester ratio further toward shorter-acting nandrolone for users who want faster clearance without abandoning the decanoate base entirely |
Side Effects & Management
Nandrolone's side effect profile is distinct from testosterone in two key ways: much lower androgenic activity in sensitive tissues, and prolactin/progesterone-mediated effects that require cabergoline rather than standard AIs for management. Understanding this distinction prevents the common error of treating nandrolone gyno with an aromatase inhibitor, which addresses estrogen but not the prolactin mechanism.
| What May Occur | Background | How to Handle It |
|---|---|---|
| Prolactin elevation and prolactin-related gynecomastia | Nandrolone binds progesterone receptors and elevates serum prolactin through this progestogenic mechanism; elevated prolactin causes breast tissue sensitivity and can progress to glandular gynecomastia that does not respond to aromatase inhibitors (because it is prolactin-driven, not estrogen-driven); prolactin-related gyno presents as nipple sensitivity with discharge, distinguishing it from estrogen gyno which typically presents as palpable glandular tissue without discharge | Prolactin blood work before and every 6–8 weeks on cycle; Caberlin (Cabergoline) at 0.25–0.5 mg twice weekly is the primary prolactin management tool — it is a dopamine agonist that directly suppresses prolactin secretion from the pituitary; standard aromatase inhibitors (Arimidex DP, Aromasin DP) are still used to manage estrogen from the testosterone base but do not address nandrolone-driven prolactin; cabergoline is required specifically for the prolactin component |
| Sexual dysfunction ("Deca Dick") | Sexual dysfunction with nandrolone use has two distinct causes that often occur together: first, nandrolone displaces testosterone at androgen receptors in sexual tissue but dihydronandrolone (nandrolone's 5-AR metabolite) is far weaker than DHT, leaving androgen tone in sexual tissue insufficient; second, elevated prolactin directly suppresses libido and erectile function at the central level; running nandrolone without adequate exogenous testosterone dramatically worsens this effect by also removing testosterone's contribution to DHT production | Adequate testosterone base (minimum 200 mg/week, ideally 300–400 mg/week) prevents the androgen deficit mechanism; cabergoline management addresses prolactin suppression of libido; Proviron Dragon Pharma (mesterolone) adds DHT at androgen receptors in sexual tissue and meaningfully improves libido and erectile quality when used alongside nandrolone cycles at 25–50 mg/day; for acute erectile dysfunction, Cialis DP Dragon Pharma provides on-demand support |
| HPTA suppression | Nandrolone is highly suppressive — it shuts down LH and FSH production within 2–4 weeks; because the testosterone base in the stack also suppresses the HPT axis, recovery after a nandrolone + testosterone cycle requires PCT that adequately addresses both; the decanoate ester's long half-life means nandrolone remains active for 3–4 weeks after the last injection, so PCT timing must account for clearance of both the nandrolone and the testosterone ester | PCT starts 3 weeks after the last injection of Deca 200 / NPP 150 (to allow both esters to clear sufficiently); Nolvadex Dragon Pharma and Clomid Dragon Pharma as per standard PCT protocol; see the PCT section below for full protocol detail |
| Water retention | Nandrolone's low aromatization rate produces less estrogen-driven water retention than testosterone, but some retention still occurs via progesterone-mediated mechanisms and the water-retaining effects of the testosterone base in the stack; the net water retention on a test + nandrolone cycle is typically less than a test-only cycle at equivalent anabolic doses | Aromatase inhibitor use for the testosterone component manages the estrogen contribution; maintaining reasonable sodium intake and avoiding excessive caloric surplus reduces retention; if water retention remains uncomfortable, dose adjustment of the testosterone component is more effective than the nandrolone component given the difference in aromatization rates |
| Cardiovascular: HDL reduction | Like all anabolic steroids, nandrolone suppresses HDL cholesterol; the effect is moderate and generally less pronounced than with 17-alpha alkylated orals or high-dose testosterone, but it is additive with the testosterone base in the stack; long cycles (16+ weeks) at higher doses produce more significant lipid impact | Lipid panel at baseline and mid-cycle; omega-3 supplementation (3–4 g/day EPA+DHA); cardiovascular training maintained throughout cycle; for persistent HDL suppression, Atorlip (Atorvastatin) or Rosulip (Rosuvastatin) can be added |
PCT
PCT timing for Deca 200 / NPP 150 is governed by the decanoate ester — the longer of the two. With a ~15-day half-life, nandrolone decanoate requires approximately 3 weeks after the last injection before plasma levels fall far enough for SERMs to be effective. Starting PCT too early while nandrolone is still active works against the SERM stimulus and produces poor recovery. Blood work at 4–6 weeks post-PCT (testosterone, LH, FSH, prolactin) confirms full HPT axis recovery.
| Phase | Products | Protocol |
|---|---|---|
| On cycle — prolactin control | Caberlin (Cabergoline) | 0.25–0.5 mg twice weekly throughout the cycle; cabergoline is a dopamine agonist that directly suppresses prolactin secretion; begin at the first injection and continue for 2–3 weeks into PCT if prolactin was elevated — prolactin normalizes more slowly than sex hormones and early discontinuation risks post-cycle rebound |
| Wait before PCT | — | Approximately 21 days (3 weeks) after the last injection; the decanoate ester requires this clearance window before SERM therapy becomes effective; starting PCT while nandrolone is still substantially active blunts HPT axis recovery |
| PCT weeks 1–2 | Clomid Dragon Pharma + Nolvadex Dragon Pharma | Clomid 50 mg/day + Nolvadex 40 mg/day; Clomid drives LH and FSH recovery at both hypothalamic and pituitary level; Nolvadex provides complementary LH stimulation and breast tissue protection; the combination is more effective than either SERM alone after a highly suppressive nandrolone + testosterone cycle |
| PCT weeks 3–4 | Clomid Dragon Pharma + Nolvadex Dragon Pharma | Clomid 25 mg/day + Nolvadex 20 mg/day; taper as LH and FSH re-establish; extend to 6 weeks total for longer cycles (16+ weeks) or if mid-PCT blood work shows incomplete recovery |
References
| Source | Topic | Link |
|---|---|---|
| PubMed / Clinical Rheumatology | Nandrolone decanoate pharmacology — anabolic steroid properties, therapeutic use context, effects on calcium balance, muscle mass, bone-related outcomes, and clinical application in osteoporosis | Geusens, 1995 ↗ |
| PubMed / Metabolism | Anabolic steroids and collagen synthesis — evidence that anabolic steroid therapy can stimulate type III collagen synthesis in postmenopausal women | Hassager et al., 1990 ↗ |
| NCBI Bookshelf / StatPearls | Hyperprolactinemia physiology — prolactin elevation, reproductive dysfunction, hypogonadism, drug-induced causes, diagnostic evaluation, and dopamine agonist treatment context | StatPearls: Hyperprolactinemia ↗ |
| PubMed / Systematic Reviews | Cabergoline and hyperprolactinemia — dopamine agonist therapy, prolactin reduction, comparison with bromocriptine, and clinical management evidence | Wang et al., 2012 ↗ |
| PubMed / Journal of Pharmacology and Experimental Therapeutics | Nandrolone ester pharmacokinetics — effects of ester type, injection site, and injection volume on nandrolone pharmacokinetics and pharmacodynamics, including phenylpropionate versus longer esters | Minto et al., 1997 ↗ |
| PubMed / J Clin Endocrinol Metab | Nandrolone decanoate pharmacokinetics — serum and urine nandrolone/metabolite profiles after intramuscular nandrolone decanoate dosing in healthy men | Bagchus et al., 2005 ↗ |
What is NPP 150 used for?
NPP 150, part of this blend, promotes muscle growth and joint support in bulking; see Key Benefits. It suits bodybuilders—consult professionals for safe use.
What does Deca 200 / NPP 150 do?
It enhances muscle mass, strength, and joint health via nandrolone; see Mechanism of Action. It delivers robust gains—monitor with labs.
How long does Deca 200 / NPP 150 stay in your system?
With half-lives of 2-7 days, it's detectable for 12-18 months; see Mechanism of Action. Plan PCT accordingly—consult professionals.
How to use Deca 200 / NPP 150?
Inject 350-700 mg/week, split weekly; see How to Use. Use with diet and monitoring—consult for tailored plans.
Is Deca 200 / NPP 150 dangerous?
It's safe with proper use and monitoring; see Side Effects. Risks are manageable with ancillaries—consult professionals for safety.
What are the main benefits of Deca 200 / NPP 150?
Deca 200 / NPP 150 is most often associated with bulking and lean mass-building phases, although some users also incorporate it into recomposition-focused programs.
What makes Deca 200 / NPP 150 different from standard Deca products?
Unlike traditional Deca-only formulations, Deca 200 / NPP 150 combines both long-acting and short-acting nandrolone esters, offering a balance of quicker onset and sustained activity.
Is Deca 200 / NPP 150 better for bulking or recomposition?
Deca 200 / NPP 150 is most often associated with bulking and lean mass-building phases, although some users also incorporate it into recomposition-focused programs.
Related Products
